Explore Business Standard
IVF Treatment
Fertility services provider Indira IVF Hospital Ltd has confidentially filed draft papers with markets regulator Sebi to raise funds through an initial public offering (IPO), according to a public announcement on Wednesday. The development comes amidst growing investor interest in the Indian assisted reproductive technology (ART) sector, buoyed by increasing awareness, expanding market size, and favourable demographics. In a public announcement, Indira IVF stated that it has submitted "the pre-filed draft red herring prospectus with Sebi and the stock exchanges... in relation to the proposed initial public offering of its equity shares on the main board of the stock exchanges." The confidential pre-filing route allows the company to withhold public disclosure of details under the draft red herring prospectus (DRHP). Further, pre-filing DRHP does not guarantee the company will go ahead with the initial public offering (IPO). Meanwhile, market sources said Gaudium IVF and Women Healt
Fertility clinic chain Indira IVF Hospital has withdrawn its draft IPO papers, which were filed through the confidential route, an update with markets regulator Sebi showed on Tuesday. The confidential pre-filing route allows the company to withhold public disclosure of details under the draft red herring prospectus (DRHP). Further, pre-filing DRHP does not guarantee the company will go ahead with the initial public offering (IPO). The preliminary IPO papers were received by the Securities and Exchange Board of India (Sebi) on February 13, however, "draft offer document (was) withdrawn on March 19, 2025" by the company without disclosing any reasons. Last week, PhysicsWallah joined the league of a handful of companies that took confidential filing routes for its IPO. In 2024, food delivery giant Swiggy and supermart major Vishal Mega Mart successfully floated their respective initial share sales after making confidential filings. Before this, online hotel aggregator OYO took the .
President Donald Trump has signed an executive order meant to expand access to and reduce costs of in vitro fertilisation and issued a presidential memorandum calling for radical transparency requirements from the government, which he suggested could reduce wasteful spending. On the campaign trail, Trump called for universal coverage of IVF treatment after his Supreme Court nominees helped to overturn Roe v. Wade, leading to a wave of restrictions in Republican-led states, including some that have threatened access to IVF by trying to define life as beginning at conception. Trump, who was at his Florida residence and club, Mar-a-Lago, on Tuesday, also signed another executive order as well as a presidential memorandum. The second executive order outlined the oversight functions of the Office of Management and Budget, while the memo requires the government to detail the waste, fraud and abuse that's found as the Department of Government Efficiency, overseen by Tesla CEO Elon Musk, ...
The Defence Department will no longer reimburse service members for travel out of state to get reproductive health care, including abortions and fertility treatments, according to a new memo. The directive signed this week eliminates a rarely used Biden administration policy enacted in October 2022, after the Supreme Court overturned Roe v. Wade and more states began to impose increased abortion restrictions. Signed on Wednesday by Jeffrey Register, the director of the Pentagon's human resources department, the memo simply shows red lines crossing out the previous regulation and offers no other guidance. Asked if service members would still be allowed time off to travel at their own expense, the department had no immediate answer. Sen. Elizabeth Warren, D-Mass., a member of the Senate Armed Services Committee, called the policy change shameful. Our service members go wherever they need to in order to bravely serve our country and because President Trump's extremist Supreme Court